ZAFIRLUKAST
- DRL net up at Rs 273 crore on strong generic sales in USDr Reddy's Laboratories' third quarter net profit rose to Rs 273.2 crore against a net loss of 521.7 crore in the same quarter previous yea...
- Dr Reddy's gets FDA nod to launch anti-asthma tablets in USDrug firm Dr Reddy's Laboratories today said it has received approval from US health regulator to launch generic Zafirlukast tablets, used ...
- Load More